This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Shouyao Holdings (Beijing) Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Baokun Yuan - Innovator in Pharmaceutical Development
Introduction
Baokun Yuan is an accomplished inventor based in Beijing, China. He is currently associated with Shouyao Holdings Co., Ltd., where he contributes to the field of pharmaceutical innovations. Despite having no granted patents to his name, his work in developing selective inhibitors showcases his commitment to advancing medical science.
Latest Patent Applications
Baokun Yuan has been involved in several notable patent applications. One of his latest applications is for an RET selective inhibitor, which includes a preparation method and its use. This invention provides a compound of formula (1) and a pharmaceutically accepted salt, solvate, polymorph, or tautomer thereof, along with a composition comprising these compounds. The application emphasizes the use of these compounds in treating diseases related to RET. Another significant application is for an FGFR4 kinase inhibitor, which also includes a preparation method and its use. This invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, or tautomer thereof, and its application in manufacturing a medicament for treating FGFR4 mediated diseases.
Conclusion
Baokun Yuan is a dedicated inventor whose work in pharmaceutical development holds promise for future medical advancements. His innovative approaches to selective inhibitors reflect his expertise and commitment to improving healthcare solutions.